Arrayit Corporation,
leads and empowers the genetic, research, pharmaceutical, and diagnostic communities
through the discovery, development and manufacture of proprietary life science
technologies and consumables for disease prevention, treatment and cure, announces
that on September 11th, 2009 Arrayit delivered its proprietary nanotechnology
platform to Sandia National Laboratories in Albuquerque, New Mexico. Sandia
Labs, managed by the Lockheed Martin Corporation, works with the Transportation
Security Administration (TSA) and the Department of Homeland Security to enhance
national security.
Sandia will utilize Arrayit's proprietary nanotechnology manufacturing platform,
which empowers researchers to create microarrays, biosensors and "chemical
noses" that detect the biological and chemical agents used in lethal terrorist
attacks. Arrayit's patented delivery system deposits nanoliter quantities of
analytical reagents onto proprietary substrates to create the sophisticated
detection devices.
"We are pleased to receive this contract from the prestigious Sandia Labs,"
states Rene Schena, CEO and co-founder of Arrayit Corp. "We look forward
to leveraging our unique and patented nanotechnology capabilities to enhance
national safety."
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers
the genetic, research, pharmaceutical, and diagnostic communities through the
discovery, development and manufacture of proprietary life science technologies
and consumables for disease prevention, treatment and cure. It now offers over
650 products to a customer base of more than 2,500 laboratories worldwide, including
most every major university, pharmaceutical and biotech company, major agricultural
and chemical company, government agency, national research foundation and many
private sector enterprises.